Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues -: a comparative immunohistochemical study

被引:48
|
作者
Biswas, S [1 ]
Bhattacherjee, P [1 ]
Paterson, CA [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA
关键词
D O I
10.1016/j.plefa.2004.03.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of the present study was to compare the localization of prostaglandin E-2 receptor subtypes in normal human and mouse ocular tissues. Paraffin embedded sections of normal human and mouse (129 Sv/Ev) eyes were treated with EP1, EP2, EP3 and EP4 specific antibodies and subsequently incubated with Alexa Fluor secondary antibody (Ex/Em = 555/571) to detect the presence of EP receptor proteins. Fluorescence of the localized antibodies was visualized in a Carl Zeiss Microscope (Axiovert 200) and photographed using Carl Zeiss Axiocam camera. In mice EP, and EP3 receptor subtypes were only moderately expressed, EP3 receptor expression being almost negligible. In human cornea and iris ciliary body, EP1 and EP3 receptors were prominently expressed. EP4 receptor was expressed moderately in human and mouse ocular tissues. EP2 receptor was the most prominently and abundantly expressed receptor in both human and mouse ocular tissues. It is concluded that the pattern of the distribution of EP receptor subtypes in the ocular tissues are similar in human and mouse. Thus, 129 Sv/Ev strains of mice would make an appropriate animal model for studying the ocular pathophysiological roles of prostaglandin receptor agonists. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:277 / 288
页数:12
相关论文
共 50 条
  • [31] Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys
    Schweda, F
    Klar, J
    Narumiya, S
    Nüsing, RM
    Kurtz, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) : F427 - F433
  • [32] Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis
    Kurihara, Y
    Endo, H
    Akahoshi, T
    Kondo, H
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (02): : 323 - 330
  • [33] Differential regulation of rheumatoid synoviocyte prostaglandin E receptor subtypes, EP1 and EP2, in response to dexamethasone and prostaglandin E(2).
    McCarthy, CJ
    Hetisimer, A
    Tan, B
    Crofford, LJ
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 331 - 331
  • [34] EP2 and EP4 receptor subtypes in human bone marrow stromal cells
    Desplat, V
    Petit, B
    Trimoreau, F
    Praloran, V
    Denizot, Y
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) : 421 - 422
  • [35] Expression of prostaglandin E2 receptor subtypes, EP2 and EP4, in the rat hippocampus after cerebral ischemia and ischemic tolerance
    Choi, JS
    Kim, HY
    Chun, MH
    Chung, JW
    Lee, MY
    [J]. CELL AND TISSUE RESEARCH, 2006, 324 (02) : 203 - 211
  • [36] Cooperation of the EP2, EP3 and EP4 receptors in regulation of prostaglandin E2-induced human brain microvascular endothelial cell migration
    Khan, Gausal A.
    Konger, Raymond
    Risso, Maria Teresa
    [J]. CIRCULATION, 2006, 114 (18) : 145 - 145
  • [37] EP2 and EP4 prostanoid receptor signaling
    Regan, JW
    [J]. LIFE SCIENCES, 2003, 74 (2-3) : 143 - 153
  • [38] EP1 and EP4 receptors mediate prostaglandin E2 actions in the microcirculation of rat kidney
    Purdy, KE
    Arendshorst, WJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (04) : F755 - F764
  • [39] Expression of prostaglandin E2 receptor subtypes, EP2 and EP4, in the rat hippocampus after cerebral ischemia and ischemic tolerance
    Jeong-Sun Choi
    Ha-Young Kim
    Myung-Hoon Chun
    Jin-Woong Chung
    Mun-Yong Lee
    [J]. Cell and Tissue Research, 2006, 324 : 203 - 211
  • [40] Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice
    Nakano, H
    Kobayashi, T
    Sugimoto, Y
    Ushikubi, F
    Ichikawa, A
    Narumiya, S
    Ito, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (03) : 438 - 444